Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Capecitabine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Capecitabine market. Detailed analysis of key players, along with key growth strategies adopted by Capecitabine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Mylan
Hengrui Medicine
Hetero
Reliance Group
Cipla
Teva
Hikma
Roche
By Type:
500 mg
150 mg
By End-User:
Breast Cancer
Colorectal Cancer
Stomach Cancer
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Capecitabine Market
-
1.3 Market Segment by Type
-
1.3.1 USA Capecitabine Market Size and Growth Rate of 500 mg from 2016 to 2027
-
1.3.2 USA Capecitabine Market Size and Growth Rate of 150 mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Capecitabine Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 USA Capecitabine Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
1.4.3 USA Capecitabine Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Capecitabine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Capecitabine by Major Types
-
3.4.1 Market Size and Growth Rate of 500 mg
-
3.4.2 Market Size and Growth Rate of 150 mg
4 Segmentation of Capecitabine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Capecitabine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Capecitabine in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Capecitabine in Colorectal Cancer
-
4.4.3 Market Size and Growth Rate of Capecitabine in Stomach Cancer
5 Market Analysis by Regions
-
5.1 USA Capecitabine Production Analysis by Regions
-
5.2 USA Capecitabine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Capecitabine Landscape Analysis
-
6.1 West USA Capecitabine Landscape Analysis by Major Types
-
6.2 West USA Capecitabine Landscape Analysis by Major End-Users
7 South USA Capecitabine Landscape Analysis
-
7.1 South USA Capecitabine Landscape Analysis by Major Types
-
7.2 South USA Capecitabine Landscape Analysis by Major End-Users
8 Middle West USA Capecitabine Landscape Analysis
-
8.1 Middle West USA Capecitabine Landscape Analysis by Major Types
-
8.2 Middle West USA Capecitabine Landscape Analysis by Major End-Users
9 Northeast USA Capecitabine Landscape Analysis
-
9.1 Northeast USA Capecitabine Landscape Analysis by Major Types
-
9.2 Northeast USA Capecitabine Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Mylan
-
10.1.1 Mylan Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Hengrui Medicine
-
10.2.1 Hengrui Medicine Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Hetero
-
10.3.1 Hetero Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Reliance Group
-
10.4.1 Reliance Group Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Cipla
-
10.5.1 Cipla Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Teva
-
10.6.1 Teva Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Hikma
-
10.7.1 Hikma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Roche
-
10.8.1 Roche Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Capecitabine Market Size and Growth Rate of 500 mg from 2016 to 2027
-
Figure USA Capecitabine Market Size and Growth Rate of 150 mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Capecitabine Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Capecitabine Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
Figure USA Capecitabine Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Capecitabine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Capecitabine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Capecitabine
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Capecitabine by Different Types from 2016 to 2027
-
Table Consumption Share of Capecitabine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 500 mg
-
Figure Market Size and Growth Rate of 150 mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Capecitabine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Capecitabine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Colorectal Cancer
-
Figure Market Size and Growth Rate of Stomach Cancer
-
Table USA Capecitabine Production by Regions
-
Table USA Capecitabine Production Share by Regions
-
Figure USA Capecitabine Production Share by Regions in 2016
-
Figure USA Capecitabine Production Share by Regions in 2021
-
Figure USA Capecitabine Production Share by Regions in 2027
-
Table USA Capecitabine Consumption by Regions
-
Table USA Capecitabine Consumption Share by Regions
-
Figure USA Capecitabine Consumption Share by Regions in 2016
-
Figure USA Capecitabine Consumption Share by Regions in 2021
-
Figure USA Capecitabine Consumption Share by Regions in 2027
-
Table West USA Capecitabine Consumption by Types from 2016 to 2027
-
Table West USA Capecitabine Consumption Share by Types from 2016 to 2027
-
Figure West USA Capecitabine Consumption Share by Types in 2016
-
Figure West USA Capecitabine Consumption Share by Types in 2021
-
Figure West USA Capecitabine Consumption Share by Types in 2027
-
Table West USA Capecitabine Consumption by End-Users from 2016 to 2027
-
Table West USA Capecitabine Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Capecitabine Consumption Share by End-Users in 2016
-
Figure West USA Capecitabine Consumption Share by End-Users in 2021
-
Figure West USA Capecitabine Consumption Share by End-Users in 2027
-
Table South USA Capecitabine Consumption by Types from 2016 to 2027
-
Table South USA Capecitabine Consumption Share by Types from 2016 to 2027
-
Figure South USA Capecitabine Consumption Share by Types in 2016
-
Figure South USA Capecitabine Consumption Share by Types in 2021
-
Figure South USA Capecitabine Consumption Share by Types in 2027
-
Table South USA Capecitabine Consumption by End-Users from 2016 to 2027
-
Table South USA Capecitabine Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Capecitabine Consumption Share by End-Users in 2016
-
Figure South USA Capecitabine Consumption Share by End-Users in 2021
-
Figure South USA Capecitabine Consumption Share by End-Users in 2027
-
Table Middle West USA Capecitabine Consumption by Types from 2016 to 2027
-
Table Middle West USA Capecitabine Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Capecitabine Consumption Share by Types in 2016
-
Figure Middle West USA Capecitabine Consumption Share by Types in 2021
-
Figure Middle West USA Capecitabine Consumption Share by Types in 2027
-
Table Middle West USA Capecitabine Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Capecitabine Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Capecitabine Consumption Share by End-Users in 2016
-
Figure Middle West USA Capecitabine Consumption Share by End-Users in 2021
-
Figure Middle West USA Capecitabine Consumption Share by End-Users in 2027
-
Table Northeast USA Capecitabine Consumption by Types from 2016 to 2027
-
Table Northeast USA Capecitabine Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Capecitabine Consumption Share by Types in 2016
-
Figure Northeast USA Capecitabine Consumption Share by Types in 2021
-
Figure Northeast USA Capecitabine Consumption Share by Types in 2027
-
Table Northeast USA Capecitabine Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Capecitabine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Capecitabine Consumption Share by End-Users in 2016
-
Figure Northeast USA Capecitabine Consumption Share by End-Users in 2021
-
Figure Northeast USA Capecitabine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Hengrui Medicine
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hengrui Medicine
-
Figure Sales and Growth Rate Analysis of Hengrui Medicine
-
Figure Revenue and Market Share Analysis of Hengrui Medicine
-
Table Product and Service Introduction of Hengrui Medicine
-
Table Company Profile and Development Status of Hetero
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hetero
-
Figure Sales and Growth Rate Analysis of Hetero
-
Figure Revenue and Market Share Analysis of Hetero
-
Table Product and Service Introduction of Hetero
-
Table Company Profile and Development Status of Reliance Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reliance Group
-
Figure Sales and Growth Rate Analysis of Reliance Group
-
Figure Revenue and Market Share Analysis of Reliance Group
-
Table Product and Service Introduction of Reliance Group
-
Table Company Profile and Development Status of Cipla
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
-
Figure Sales and Growth Rate Analysis of Cipla
-
Figure Revenue and Market Share Analysis of Cipla
-
Table Product and Service Introduction of Cipla
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Hikma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma
-
Figure Sales and Growth Rate Analysis of Hikma
-
Figure Revenue and Market Share Analysis of Hikma
-
Table Product and Service Introduction of Hikma
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
